PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer killing drugs at the source of cancer.
Quote | PharmaCyte Biotech Inc. (OTCMKTS:PMCB)
Last: | $3.03 |
---|---|
Change Percent: | -56.71% |
Open: | $3.08 |
Close: | $3.03 |
High: | $3.14 |
Low: | $2.92 |
Volume: | 1,774,614 |
Last Trade Date Time: | 08/10/2021 04:41:14 am |
News | PharmaCyte Biotech Inc. (OTCMKTS:PMCB)
2024-05-21 09:16:11 ET More on MyMD Pharmaceuticals, PharmaCyte Biotech, Inc., etc. Financial information for MyMD Pharmaceuticals Financial information for PharmaCyte Biotech, Inc. Read the full article on Seeking Alpha For further details see: PharmaCyt...
Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to create additional stockholder value PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”), today announced a $7 mi...
Message Board Posts | PharmaCyte Biotech Inc. (OTCMKTS:PMCB)
Subject | By | Source | When |
---|---|---|---|
Maybe Iroquois forgot they have $PMCB. | Diana15 | investorshub | 04/26/2023 6:34:27 PM |
I believe. | saladan2 | investorshub | 04/22/2023 9:34:31 PM |
I agreed and copy that | $Pistol Pete$ | investorshub | 04/12/2023 6:13:38 PM |
Believe or not, Iroquois is worst than Kenny | Diana15 | investorshub | 04/11/2023 9:12:12 AM |
lmao | longboarder7892 | investorshub | 04/10/2023 11:55:53 PM |
News, Short Squeeze, Breakout and More Instantly...
PharmaCyte Biotech Inc. Company Name:
PMCB Stock Symbol:
OTCMKTS Market:
PharmaCyte Biotech Inc. Website:
Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to create additional stockholder value PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”), today announced a $7 mi...